CellCarta, a medical services company, completed the acquisition of Biogazelle, a laboratory services provider. Financial terms were not disclosed. “Biogazelle’s exceptional genomics expertise will enable CellCarta to further support its clients’ therapeutic development strategies, offering them key solutions to address their clinical challenges and move their immunology and other programs forward,” Martin LeBlanc, CellCarta CEO.